FDA head suspects economic motives behind tainted heparin

04/15/2008 | Wall Street Journal (free content), The · Bloomberg11

FDA Commissioner Andrew von Eschenbach told a Senate Appropriations subcommittee that the agency believes batches of Baxter International's blood thinner heparin may have been contaminated "by virtue of economic fraud." After the hearing, however, von Eschenbach told reporters that the agency had no proof the contamination was committed on purpose.

View Full Article in:

Wall Street Journal (free content), The · Bloomberg11

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Deputy Director, Marketing
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Director of Operations - GBS
Mayo Clinic
MN
Director of Actuarial Services, Government Programs
PacificSource
OR
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC